A randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacy, safety and tolerability of CR4056 administered for 2 weeks in patients with osteoarthritis of the knee with moderate to severe chronic pain (with or without a neuropathic component)

Trial Profile

A randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacy, safety and tolerability of CR4056 administered for 2 weeks in patients with osteoarthritis of the knee with moderate to severe chronic pain (with or without a neuropathic component)

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Jul 2017

At a glance

  • Drugs CR 4056 (Primary)
  • Indications Osteoarthritis
  • Focus Therapeutic Use
  • Sponsors Rottapharm Madaus
  • Most Recent Events

    • 30 Sep 2016 Status changed from recruiting to completed.
    • 08 Sep 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top